表紙
市場調查報告書

結核治療藥的全球市場

Tuberculosis Therapeutics

出版商 Global Industry Analysts, Inc. 商品編碼 912762
出版日期 內容資訊 英文 240 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
結核治療藥的全球市場 Tuberculosis Therapeutics
出版日期: 2019年10月01日內容資訊: 英文 240 Pages
簡介

本報告提供全球結核治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 簡介·調查手法·調查範圍

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球結核治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ASTRAZENECA PLC
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • LUPIN LTD.
  • MERCK & CO., INC.
  • 大塚製藥
  • PANACEA BIOTEC LTD.
  • PFIZER, INC

第5章 調查資料

目錄
Product Code: MCP-6337

Tuberculosis Therapeutics market worldwide is projected to grow by US$376.1 Million, driven by a compounded growth of 4.9%. Active TB, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$810.1 Million by the year 2025, Active TB will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$13.2 Million to the region's size and clout in the next 5 to 6 years. Over US$10.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Active TB will reach a market size of US$43.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.9% over the next couple of years and add approximately US$110.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, AstraZeneca PLC; Eli Lilly and Company; GlaxoSmithKline PLC; Johnson & Johnson; Lupin Ltd.; Merck & Co., Inc.; Otsuka Pharmaceutical Co., Ltd.; Panacea Biotec Ltd.; Pfizer, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Tuberculosis Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Tuberculosis Therapeutics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Tuberculosis Therapeutics Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
  • TABLE 3: Tuberculosis Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Active TB (Disease Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 5: Active TB (Disease Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 6: Active TB (Disease Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Latent TB (Disease Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 8: Latent TB (Disease Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 9: Latent TB (Disease Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: First-Line Therapy (Therapy) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 11: First-Line Therapy (Therapy) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
  • TABLE 12: First-Line Therapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Second-Line Therapy (Therapy) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 14: Second-Line Therapy (Therapy) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 15: Second-Line Therapy (Therapy) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Tuberculosis Therapeutics Market Share (in %) by Company: 2019 & 2025
    • TABLE 16: United States Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 17: Tuberculosis Therapeutics Market in the United States by Disease Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 18: United States Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 19: United States Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Therapy: 2018 to 2025
    • TABLE 20: Tuberculosis Therapeutics Market in the United States by Therapy: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 21: United States Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 22: Canadian Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 23: Canadian Tuberculosis Therapeutics Historic Market Review by Disease Type in US$ Thousand: 2009-2017
    • TABLE 24: Tuberculosis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
    • TABLE 25: Canadian Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018 to 2025
    • TABLE 26: Canadian Tuberculosis Therapeutics Historic Market Review by Therapy in US$ Thousand: 2009-2017
    • TABLE 27: Tuberculosis Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • JAPAN
    • TABLE 28: Japanese Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 29: Tuberculosis Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017
    • TABLE 30: Japanese Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 31: Japanese Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 32: Tuberculosis Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2009-2017
    • TABLE 33: Japanese Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 34: Chinese Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 35: Tuberculosis Therapeutics Historic Market Analysis in China in US$ Thousand by Disease Type: 2009-2017
    • TABLE 36: Chinese Tuberculosis Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 37: Chinese Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 38: Tuberculosis Therapeutics Historic Market Analysis in China in US$ Thousand by Therapy: 2009-2017
    • TABLE 39: Chinese Tuberculosis Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Tuberculosis Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 40: European Tuberculosis Therapeutics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 41: Tuberculosis Therapeutics Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 42: European Tuberculosis Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 43: European Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025
    • TABLE 44: Tuberculosis Therapeutics Market in Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 45: European Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 46: European Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025
    • TABLE 47: Tuberculosis Therapeutics Market in Europe in US$ Thousand by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 48: European Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 49: Tuberculosis Therapeutics Market in France by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 50: French Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Disease Type: 2009-2017
    • TABLE 51: French Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 52: Tuberculosis Therapeutics Market in France by Therapy: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 53: French Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Therapy: 2009-2017
    • TABLE 54: French Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 55: Tuberculosis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 56: German Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017
    • TABLE 57: German Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 58: Tuberculosis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 59: German Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
    • TABLE 60: German Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 61: Italian Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 62: Tuberculosis Therapeutics Historic Market Analysis in Italy in US$ Thousand by Disease Type: 2009-2017
    • TABLE 63: Italian Tuberculosis Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 64: Italian Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 65: Tuberculosis Therapeutics Historic Market Analysis in Italy in US$ Thousand by Therapy: 2009-2017
    • TABLE 66: Italian Tuberculosis Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 67: United Kingdom Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 68: Tuberculosis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017
    • TABLE 69: United Kingdom Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 70: United Kingdom Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 71: Tuberculosis Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2009-2017
    • TABLE 72: United Kingdom Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 73: Spanish Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 74: Spanish Tuberculosis Therapeutics Historic Market Review by Disease Type in US$ Thousand: 2009-2017
    • TABLE 75: Tuberculosis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
    • TABLE 76: Spanish Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018 to 2025
    • TABLE 77: Spanish Tuberculosis Therapeutics Historic Market Review by Therapy in US$ Thousand: 2009-2017
    • TABLE 78: Tuberculosis Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 79: Russian Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 80: Tuberculosis Therapeutics Market in Russia by Disease Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 81: Russian Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 82: Russian Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Therapy: 2018 to 2025
    • TABLE 83: Tuberculosis Therapeutics Market in Russia by Therapy: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 84: Russian Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 85: Rest of Europe Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025
    • TABLE 86: Tuberculosis Therapeutics Market in Rest of Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 87: Rest of Europe Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 88: Rest of Europe Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025
    • TABLE 89: Tuberculosis Therapeutics Market in Rest of Europe in US$ Thousand by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 90: Rest of Europe Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 91: Asia-Pacific Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
    • TABLE 92: Tuberculosis Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 93: Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 94: Tuberculosis Therapeutics Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 95: Asia-Pacific Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Disease Type: 2009-2017
    • TABLE 96: Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 97: Tuberculosis Therapeutics Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 98: Asia-Pacific Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Therapy: 2009-2017
    • TABLE 99: Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 100: Tuberculosis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 101: Australian Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017
    • TABLE 102: Australian Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 103: Tuberculosis Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 104: Australian Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
    • TABLE 105: Australian Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 106: Indian Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 107: Indian Tuberculosis Therapeutics Historic Market Review by Disease Type in US$ Thousand: 2009-2017
    • TABLE 108: Tuberculosis Therapeutics Market in India: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
    • TABLE 109: Indian Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018 to 2025
    • TABLE 110: Indian Tuberculosis Therapeutics Historic Market Review by Therapy in US$ Thousand: 2009-2017
    • TABLE 111: Tuberculosis Therapeutics Market in India: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 112: Tuberculosis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 113: South Korean Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017
    • TABLE 114: Tuberculosis Therapeutics Market Share Distribution in South Korea by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 115: Tuberculosis Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 116: South Korean Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
    • TABLE 117: Tuberculosis Therapeutics Market Share Distribution in South Korea by Therapy: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 118: Rest of Asia-Pacific Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 119: Tuberculosis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017
    • TABLE 120: Rest of Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 121: Rest of Asia-Pacific Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 122: Tuberculosis Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2009-2017
    • TABLE 123: Rest of Asia-Pacific Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 124: Latin American Tuberculosis Therapeutics Market Trends by Region/Country in US$ Thousand: 2018-2025
    • TABLE 125: Tuberculosis Therapeutics Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 126: Latin American Tuberculosis Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 127: Latin American Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 128: Tuberculosis Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Disease Type: 2009-2017
    • TABLE 129: Latin American Tuberculosis Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 130: Latin American Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 131: Tuberculosis Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Therapy: 2009-2017
    • TABLE 132: Latin American Tuberculosis Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 133: Argentinean Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025
    • TABLE 134: Tuberculosis Therapeutics Market in Argentina in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 135: Argentinean Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 136: Argentinean Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025
    • TABLE 137: Tuberculosis Therapeutics Market in Argentina in US$ Thousand by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 138: Argentinean Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 139: Tuberculosis Therapeutics Market in Brazil by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 140: Brazilian Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Disease Type: 2009-2017
    • TABLE 141: Brazilian Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 142: Tuberculosis Therapeutics Market in Brazil by Therapy: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 143: Brazilian Tuberculosis Therapeutics Historic Market Scenario in US$ Thousand by Therapy: 2009-2017
    • TABLE 144: Brazilian Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 145: Tuberculosis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 146: Mexican Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017
    • TABLE 147: Mexican Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 148: Tuberculosis Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 149: Mexican Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
    • TABLE 150: Mexican Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 151: Rest of Latin America Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 152: Tuberculosis Therapeutics Market in Rest of Latin America by Disease Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 153: Rest of Latin America Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 154: Rest of Latin America Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Therapy: 2018 to 2025
    • TABLE 155: Tuberculosis Therapeutics Market in Rest of Latin America by Therapy: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 156: Rest of Latin America Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 157: The Middle East Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
    • TABLE 158: Tuberculosis Therapeutics Market in the Middle East by Region/Country in US$ Thousand: 2009-2017
    • TABLE 159: The Middle East Tuberculosis Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 160: The Middle East Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 161: The Middle East Tuberculosis Therapeutics Historic Market by Disease Type in US$ Thousand: 2009-2017
    • TABLE 162: Tuberculosis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025
    • TABLE 163: The Middle East Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018 to 2025
    • TABLE 164: The Middle East Tuberculosis Therapeutics Historic Market by Therapy in US$ Thousand: 2009-2017
    • TABLE 165: Tuberculosis Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • IRAN
    • TABLE 166: Iranian Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 167: Tuberculosis Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017
    • TABLE 168: Iranian Tuberculosis Therapeutics Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 169: Iranian Market for Tuberculosis Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 170: Tuberculosis Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2009-2017
    • TABLE 171: Iranian Tuberculosis Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 172: Israeli Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025
    • TABLE 173: Tuberculosis Therapeutics Market in Israel in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017
    • TABLE 174: Israeli Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 175: Israeli Tuberculosis Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025
    • TABLE 176: Tuberculosis Therapeutics Market in Israel in US$ Thousand by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 177: Israeli Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 178: Saudi Arabian Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 179: Tuberculosis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Disease Type: 2009-2017
    • TABLE 180: Saudi Arabian Tuberculosis Therapeutics Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 181: Saudi Arabian Tuberculosis Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 182: Tuberculosis Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Therapy: 2009-2017
    • TABLE 183: Saudi Arabian Tuberculosis Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 184: Tuberculosis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 185: United Arab Emirates Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017
    • TABLE 186: Tuberculosis Therapeutics Market Share Distribution in United Arab Emirates by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 187: Tuberculosis Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 188: United Arab Emirates Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
    • TABLE 189: Tuberculosis Therapeutics Market Share Distribution in United Arab Emirates by Therapy: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 190: Tuberculosis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025
    • TABLE 191: Rest of Middle East Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017
    • TABLE 192: Rest of Middle East Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 193: Tuberculosis Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2018-2025
    • TABLE 194: Rest of Middle East Tuberculosis Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
    • TABLE 195: Rest of Middle East Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 196: African Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025
    • TABLE 197: Tuberculosis Therapeutics Market in Africa by Disease Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 198: African Tuberculosis Therapeutics Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
    • TABLE 199: African Tuberculosis Therapeutics Market Estimates and Projections in US$ Thousand by Therapy: 2018 to 2025
    • TABLE 200: Tuberculosis Therapeutics Market in Africa by Therapy: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 201: African Tuberculosis Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ASTRAZENECA PLC
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • LUPIN LTD.
  • MERCK & CO., INC.
  • OTSUKA PHARMACEUTICAL CO., LTD.
  • PANACEA BIOTEC LTD.
  • PFIZER, INC

V. CURATED RESEARCH

Back to Top